Evidence map›Paper›PMID 40856651›Full record

ArticleInvestigative ophthalmology & visual science2025

Hyperglycemia-Reduced Platelet-Derived Growth Factor-BB Expression Impairs Corneal Wound Healing in Diabetic Mice.

Yangyang Zhang, Rui Wang, Ya Li, Wei Zhu, Yanling Liu, Zhenzhen Zhang, Xia Qi, Huabo Chen, Qingjun Zhou, Lixin Xie

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Repair of Corneal Epithelial Defects.Progress in molecular and subcellular biology · 2026
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yangyang ZhangEye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China.
Rui WangEye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China.
Ya LiState Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Qingdao, China.
Wei ZhuAffiliated Hospital of Qingdao University, Qingdao, China.
Yanling LiuState Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Qingdao, China.
Zhenzhen ZhangEye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China.
Xia QiState Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Qingdao, China.
Huabo ChenEye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China.
Qingjun ZhouEye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China.
Lixin XieEye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study investigates the role and primary mechanisms of platelet-derived growth factor-BB (PDGF-BB) in regulating corneal epithelial injury repair and nerve regeneration under diabetic conditions. Methods: Type 1 diabetes was induced in C57BL/6 mice via streptozotocin injection. Platelet depletion was achieved using an anti-mouse GPIbα antibody. Platelet levels were quantified in intra- and extravascular compartments of the corneal limbus. Concentrations of growth factors released by activated platelets were measured in human and murine diabetic and nondiabetic samples. Diabetic mice with corneal epithelial wounds received PDGF-BB eye drops alone or combined with ERK1/2 or AKT inhibitors. Platelet-depleted mice were treated with PDGF-BB eye drops, while wild-type C57BL/6 mice received subconjunctival anti-PDGF-BB antibody injections. Human primary corneal limbal epithelial stem cells (HLECs) from diabetic and nondiabetic donors were treated with anti-PDGF-BB antibodies or PDGF-BB small interfering RNA. Results: Diabetic individuals exhibited reduced peripheral blood platelet counts and diminished PDGF-BB expression following platelet activation. Both platelet depletion and hyperglycemia impaired corneal epithelial repair and nerve regeneration, correlating with reduced PDGF-BB levels. Inhibiting PDGF-BB signaling significantly delayed corneal epithelial healing and nerve regeneration in wild-type mice. In vitro, PDGF-BB enhanced HLEC migration and proliferation. PDGF-BB promoted corneal epithelial repair and nerve regeneration in diabetic mice via ERK1/2 and AKT pathway activation. Conclusions: Hyperglycemia suppresses PDGF-BB expression, impairing corneal epithelial wound healing and nerve regeneration by inhibiting ERK1/2 and AKT signaling. PDGF-BB may represent a potential therapeutic strategy for diabetic keratopathy.

Indexed as

Corneal InjuriesDiabetes Mellitus, ExperimentalHyperglycemiaProto-Oncogene Proteins c-sisWound HealingAnimalsBecaplerminCells, CulturedDiabetes Mellitus, Type 1Epithelium, CornealHumansMaleMiceMice, Inbred C57BLBecaplerminProto-Oncogene Proteins c-sis

Identifiers

PMID40856651
PMCPMC12395822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.